Search the web
Welcome, Guest
[Sign Out, My Account]
Hoovers

Thursday, October 30 2014 12:54pm ET - U.S. Markets close in 3 hours and 6 minutes.
Industry Center
Industry Center > > ImClone Systems Corporation Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
  
ImClone Systems Corporation Company Profile
ImClone Systems wants to create identically successful cancer drug candidates. The company, a subsidiary of neuroscience products maker Eli Lilly, is focused on the development of oncology-related antibody therapies. The biotech research firm's only commercial product, Erbitux, is approved for treatment of colorectal cancer, as well as head and neck cancers. ImClone Systems co-promotes the drug with Bristol-Myers Squibb (BMS) in North America and with Merck KGaA elsewhere. The company is continuing to develop Erbitux as a possible treatment for other kinds of cancer, including lung cancer. It also has other potential oncology treatments in development.
Contact Information
Address: 440 Rte. 22 East
Bridgewater, NJ 08807
Phone:908-541-8100
Fax:
Financial Highlights
Fiscal Year End:December
Key People
President: Bernhard Ehmer
Managing Director and President: Jerry Kinzel
VP Information Technology: Jeffrey Aronowitz
Industry Information
Sector:
Industry:
Top Competitors
Amgen Inc. (amgn)
Genentech, Inc.
OSI Pharmaceuticals, LLC
 


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?